{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:36:46Z","timestamp":1792165006287,"version":"4.4.0"},"reference-count":80,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Lobular carcinoma in situ (LCIS) refers to a neoplastic proliferation of cells that characteristically shows loss of E-cadherin expression and has long been regarded as a risk factor for invasive breast cancer. Long-term outcome studies and molecular data have also implicated LCIS as a nonobligate precursor to invasive carcinoma. In the past few decades, pleomorphic and florid LCIS have been recognized as morphologic variants of LCIS with more-aggressive histopathologic features, less-favorable biomarker profiles, and more-complex molecular features compared with classic LCIS. There is still a lack of consensus regarding certain aspects of managing patients with LCIS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives.\u2014<\/jats:title>\n                    <jats:p>To review recently published literature on LCIS and to provide an overview of the current morphologic classification of LCIS, recent molecular advances, and trends in patient management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources.\u2014<\/jats:title>\n                    <jats:p>Sources included peer-reviewed, published journal articles in PubMed (US National Library of Medicine, Bethesda, Maryland) and published guidelines from the National Comprehensive Cancer Network (Fort Washington, Pennsylvania).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Lobular carcinoma in situ represents a marker for increased risk of breast cancer, as well as a nonobligate precursor to invasive carcinoma. Morphologic variants of LCIS\u2014florid and pleomorphic LCIS\u2014are genetically more-complex lesions and are more likely to be associated with invasive carcinoma. Further investigation into which molecular alterations in LCIS are associated with progression to invasive carcinoma is needed to help guide medical and surgical management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2016-0421-ra","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T10:00:55Z","timestamp":1496397655000},"page":"1668-1678","source":"Crossref","is-referenced-by-count":31,"title":["Current Concepts in Diagnosis, Molecular Features, and Management of Lobular Carcinoma In Situ of the Breast With a Discussion of Morphologic Variants"],"prefix":"10.5858","volume":"141","author":[{"given":"Paula S.","family":"Ginter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"D'Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"4","key":"2020081219445696200_i1543-2165-141-12-1668-b01","first-page":"491","article-title":"Lobular carcinoma in situ: a rare form of mammary cancer","volume":"17","author":"Foote","year":"1941","journal-title":"Am J Pathol"},{"issue":"2","key":"2020081219445696200_i1543-2165-141-12-1668-b02","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/1097-0142(197808)42:2<737::AID-CNCR2820420247>3.0.CO;2-T","article-title":"Lobular neoplasia (so-called lobular carcinoma in situ) of the breast","volume":"42","author":"Haagensen","year":"1978","journal-title":"Cancer"},{"issue":"33","key":"2020081219445696200_i1543-2165-141-12-1668-b03","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","article-title":"Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk","volume":"33","author":"King","year":"2015","journal-title":"J Clin Oncol"},{"issue":"11","key":"2020081219445696200_i1543-2165-141-12-1668-b04","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1097\/PAS.0b013e31817dc3a6","article-title":"Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile","volume":"32","author":"Chivukula","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2020081219445696200_i1543-2165-141-12-1668-b05","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/his.12353","article-title":"Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases","volume":"64","author":"Khoury","year":"2014","journal-title":"Histopathology"},{"issue":"13","key":"2020081219445696200_i1543-2165-141-12-1668-b06","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1245\/s10434-015-4552-x","article-title":"Pleomorphic lobular carcinoma in situ: radiologic-pathologic features and clinical management","volume":"22","author":"Flanagan","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"2020081219445696200_i1543-2165-141-12-1668-b07","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.humpath.2013.04.004","article-title":"Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ","volume":"44","author":"Shin","year":"2013","journal-title":"Hum Pathol"},{"issue":"11","key":"2020081219445696200_i1543-2165-141-12-1668-b08","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/PAS.0b013e3181b18a89","article-title":"Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast","volume":"33","author":"Chen","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2020081219445696200_i1543-2165-141-12-1668-b09","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s004280050469","article-title":"Mammographically detected in situ lobular carcinomas of the breast","volume":"436","author":"Sapino","year":"2000","journal-title":"Virchows Arch"},{"issue":"5","key":"2020081219445696200_i1543-2165-141-12-1668-b10","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2214\/ajr.174.5.1741245","article-title":"Core needle biopsy of challenging benign breast conditions: a comprehensive literature review","volume":"174","author":"Reynolds","year":"2000","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"2020081219445696200_i1543-2165-141-12-1668-b11","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1245\/s10434-012-2534-9","article-title":"Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia\/lobular carcinoma in situ) diagnosed on core needle biopsy","volume":"19","author":"Shah-Khan","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"2020081219445696200_i1543-2165-141-12-1668-b12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/0046-8177(91)90105-X","article-title":"Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease","volume":"22","author":"Page","year":"1991","journal-title":"Hum Pathol"},{"issue":"3","key":"2020081219445696200_i1543-2165-141-12-1668-b13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1019950918046","article-title":"Changing incidence of lobular carcinoma in situ of the breast","volume":"75","author":"Li","year":"2002","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"2020081219445696200_i1543-2165-141-12-1668-b14","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/1055-9965.EPI-04-0849","article-title":"Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001","volume":"14","author":"Li","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"2020081219445696200_i1543-2165-141-12-1668-b15","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1245\/s10434-013-3121-4","article-title":"Trends in incidence and management of lobular carcinoma in situ: a population-based analysis","volume":"20","author":"Portschy","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2020081219445696200_i1543-2165-141-12-1668-b16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00132583-199605000-00009","article-title":"Pleomorphic lobular carcinoma in situ","volume":"1","author":"Frost","year":"1996","journal-title":"Pathol Case Rev"},{"issue":"5","key":"2020081219445696200_i1543-2165-141-12-1668-b17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1309\/AJCPZHZ2TUE2UYNV","article-title":"Multinucleation is an objective feature useful in the diagnosis of pleomorphic lobular carcinoma in situ","volume":"144","author":"Blanco","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"2020081219445696200_i1543-2165-141-12-1668-b18","doi-asserted-by":"crossref","DOI":"10.1177\/1066896910370879","article-title":"Lobular neoplasia: evolution of its significance and morphologic spectrum","author":"Tavassoli","year":"2010","journal-title":"Int J Surg Pathol"},{"issue":"11","key":"2020081219445696200_i1543-2165-141-12-1668-b19","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/01.pas.0000213290.58283.82","article-title":"Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: a clinicopathologic study of 18 cases","volume":"30","author":"Fadare","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2020081219445696200_i1543-2165-141-12-1668-b20","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1245\/s10434-011-1563-0","article-title":"The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?","volume":"18","author":"Bagaria","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"2020081219445696200_i1543-2165-141-12-1668-b21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0b013e3182918a2b","article-title":"Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry","volume":"37","author":"Dabbs","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"2020081219445696200_i1543-2165-141-12-1668-b22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13058-015-0580-5","article-title":"Molecular drivers of lobular carcinoma in situ","volume":"17","author":"Logan","year":"2015","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2020081219445696200_i1543-2165-141-12-1668-b23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAI.0b013e318255bafa","article-title":"Immunohistochemistry applied to the differential diagnosis between ductal and lobular carcinoma of the breast","volume":"21","author":"de Deus Moura R, Wludarski SC, Carvalho FM, Bacchi CE","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"2020081219445696200_i1543-2165-141-12-1668-b24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/his.12869","article-title":"E-cadherin immunohistochemistry in breast pathology: uses and pitfalls","volume":"68","author":"Canas-Marques","year":"2016","journal-title":"Histopathology"},{"issue":"2","key":"2020081219445696200_i1543-2165-141-12-1668-b25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00000478-200102000-00011","article-title":"Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization","volume":"25","author":"Jacobs","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2020081219445696200_i1543-2165-141-12-1668-b26","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/1097-0142(20010815)92:4<738::AID-CNCR1377>3.0.CO;2-Z","article-title":"Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast","volume":"92","author":"Goldstein","year":"2001","journal-title":"Cancer"},{"issue":"3","key":"2020081219445696200_i1543-2165-141-12-1668-b27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/PAS.0000000000000159","article-title":"Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry [comment]","volume":"38","author":"Wells","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2020081219445696200_i1543-2165-141-12-1668-b28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10549-004-4493-8","article-title":"Biomarker profile and genetic abnormalities in lobular carcinoma in situ","volume":"90","author":"Mohsin","year":"2005","journal-title":"Breast Cancer Res Treat"},{"issue":"20","key":"2020081219445696200_i1543-2165-141-12-1668-b29","first-page":"4721","article-title":"Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia","volume":"58","author":"Lu","year":"1998","journal-title":"Cancer Res"},{"issue":"1","key":"2020081219445696200_i1543-2165-141-12-1668-b30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10549-008-9905-8","article-title":"Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast","volume":"113","author":"Green","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2020081219445696200_i1543-2165-141-12-1668-b31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/mp.53.3.118","article-title":"Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast","volume":"53","author":"Buerger","year":"2000","journal-title":"Mol Pathol"},{"issue":"3","key":"2020081219445696200_i1543-2165-141-12-1668-b32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1053\/hupa.2001.22759","article-title":"Loss of chromosome 16q in lobular carcinoma in situ","volume":"32","author":"Etzell","year":"2001","journal-title":"Hum Pathol"},{"issue":"4","key":"2020081219445696200_i1543-2165-141-12-1668-b33","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO;2-L","article-title":"Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways","volume":"187","author":"Buerger","year":"1999","journal-title":"J Pathol"},{"issue":"8","key":"2020081219445696200_i1543-2165-141-12-1668-b34","first-page":"2410","article-title":"Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization","volume":"7","author":"Gong","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2020081219445696200_i1543-2165-141-12-1668-b35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2559.2011.03918.x","article-title":"Chromosomal aberrations as detected by array comparative genomic hybridization in early low-grade intraepithelial neoplasias of the breast","volume":"59","author":"Stacher","year":"2011","journal-title":"Histopathology"},{"issue":"2","key":"2020081219445696200_i1543-2165-141-12-1668-b36","doi-asserted-by":"crossref","first-page":"M74","DOI":"10.1136\/mp.48.2.M74","article-title":"Loss of heterozygosity in lobular carcinoma in situ of the breast","volume":"48","author":"Lakhani","year":"1995","journal-title":"Clin Mol Pathol"},{"issue":"4","key":"2020081219445696200_i1543-2165-141-12-1668-b37","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.2938","article-title":"Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor-positive, invasive breast cancer","volume":"224","author":"Hungermann","year":"2011","journal-title":"J Pathol"},{"issue":"24","key":"2020081219445696200_i1543-2165-141-12-1668-b38","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1002\/j.1460-2075.1995.tb00301.x","article-title":"E-cadherin is a tumour\/invasion suppressor gene mutated in human lobular breast cancers","volume":"14","author":"Berx","year":"1995","journal-title":"EMBO J"},{"issue":"3","key":"2020081219445696200_i1543-2165-141-12-1668-b39","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1054\/bjoc.1999.0965","article-title":"Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene","volume":"82","author":"Rahman","year":"2000","journal-title":"Br J Cancer"},{"issue":"3","key":"2020081219445696200_i1543-2165-141-12-1668-b40","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ijc.1208","article-title":"Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast","volume":"92","author":"Droufakou","year":"2001","journal-title":"Int J Cancer"},{"issue":"12","key":"2020081219445696200_i1543-2165-141-12-1668-b41","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/cncr.20273","article-title":"Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma","volume":"100","author":"Hwang","year":"2004","journal-title":"Cancer"},{"issue":"2","key":"2020081219445696200_i1543-2165-141-12-1668-b42","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.molonc.2015.11.001","article-title":"Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: repertoire of somatic genetic alterations and clonal relationships","volume":"10","author":"Sakr","year":"2016","journal-title":"Mol Oncol"},{"issue":"1","key":"2020081219445696200_i1543-2165-141-12-1668-b43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13058-016-0727-z","article-title":"Clonal relationships between lobular carcinoma in situ and other breast malignancies","volume":"18","author":"Begg","year":"2016","journal-title":"Breast Cancer Res"},{"issue":"4","key":"2020081219445696200_i1543-2165-141-12-1668-b44","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.molonc.2014.12.005","article-title":"Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion","volume":"9","author":"Andrade","year":"2015","journal-title":"Mol Oncol"},{"issue":"3","key":"2020081219445696200_i1543-2165-141-12-1668-b45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.2358","article-title":"Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas","volume":"215","author":"Simpson","year":"2008","journal-title":"J Pathol"},{"issue":"11","key":"2020081219445696200_i1543-2165-141-12-1668-b46","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A","article-title":"Atypical hyperplastic lesions of the female breast: a long-term follow-up study","volume":"55","author":"Page","year":"1985","journal-title":"Cancer"},{"issue":"3","key":"2020081219445696200_i1543-2165-141-12-1668-b47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00000478-197809000-00001","article-title":"Lobular carcinoma in situ of the breast: detailed analysis of 99 patients with average follow-up of 24 years","volume":"2","author":"Rosen","year":"1978","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2020081219445696200_i1543-2165-141-12-1668-b48","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<1024::AID-CNCR12>3.0.CO;2-4","article-title":"Lobular neoplasia: long term risk of breast cancer and relation to other factors","volume":"78","author":"Bodian","year":"1996","journal-title":"Cancer"},{"issue":"7","key":"2020081219445696200_i1543-2165-141-12-1668-b49","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/ijc.28803","article-title":"Is carcinoma in situ a precursor lesion of invasive breast cancer?","volume":"135","author":"To","year":"2014","journal-title":"Int J Cancer"},{"issue":"2","key":"2020081219445696200_i1543-2165-141-12-1668-b50","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cncr.11883","article-title":"Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ","volume":"100","author":"Fisher","year":"2004","journal-title":"Cancer"},{"issue":"3","key":"2020081219445696200_i1543-2165-141-12-1668-b51","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/1097-0142(197409)34:3<554::AID-CNCR2820340313>3.0.CO;2-7","article-title":"Lobular carcinoma in situ of the breast: long-term followup","volume":"34","author":"Wheeler","year":"1974","journal-title":"Cancer"},{"issue":"13","key":"2020081219445696200_i1543-2165-141-12-1668-b52","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1245\/s10434-012-2538-5","article-title":"The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast","volume":"19","author":"Lewis","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"2020081219445696200_i1543-2165-141-12-1668-b53","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/1097-0142(196911)24:5<1081::AID-CNCR2820240534>3.0.CO;2-D","article-title":"Lobular carcinoma in situ: long term follow-up","volume":"24","author":"Hutter","year":"1969","journal-title":"Cancer"},{"issue":"2","key":"2020081219445696200_i1543-2165-141-12-1668-b54","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/jama.1967.03130020028006","article-title":"In situ lobular carcinoma: a prospective follow-up study indicating cumulative patient risks","volume":"201","author":"McDivitt","year":"1967","journal-title":"JAMA"},{"issue":"9352","key":"2020081219445696200_i1543-2165-141-12-1668-b55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(03)12230-1","article-title":"Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study","volume":"361","author":"Page","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"2020081219445696200_i1543-2165-141-12-1668-b56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pathol.2015.11.015","article-title":"Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies","volume":"48","author":"Renshaw","year":"2016","journal-title":"Pathology"},{"issue":"10","key":"2020081219445696200_i1543-2165-141-12-1668-b57","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/cncr.21864","article-title":"Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988\u20132001","volume":"106","author":"Li","year":"2006","journal-title":"Cancer"},{"issue":"2","key":"2020081219445696200_i1543-2165-141-12-1668-b58","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2214\/ajr.173.2.10430122","article-title":"Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings","volume":"173","author":"Liberman","year":"1999","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"2020081219445696200_i1543-2165-141-12-1668-b59","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/000313480807400218","article-title":"Lobular neoplasia: is surgical excision warranted?","volume":"74","author":"Sohn","year":"2008","journal-title":"Am Surg"},{"issue":"8","key":"2020081219445696200_i1543-2165-141-12-1668-b60","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/sj.bjc.6603714","article-title":"Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3)","volume":"96","author":"Houssami","year":"2007","journal-title":"Br J Cancer"},{"issue":"10","key":"2020081219445696200_i1543-2165-141-12-1668-b61","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/modpathol.2008.134","article-title":"Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary","volume":"21","author":"Hwang","year":"2008","journal-title":"Mod Pathol"},{"issue":"5","key":"2020081219445696200_i1543-2165-141-12-1668-b62","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00428-008-0607-8","article-title":"The significance of lobular neoplasia on needle core biopsy of the breast","volume":"452","author":"Menon","year":"2008","journal-title":"Virchows Arch"},{"issue":"5","key":"2020081219445696200_i1543-2165-141-12-1668-b63","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/cncr.27841","article-title":"Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision","volume":"119","author":"Murray","year":"2013","journal-title":"Cancer"},{"issue":"4","key":"2020081219445696200_i1543-2165-141-12-1668-b64","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2214\/AJR.11.8447","article-title":"Is excisional biopsy required after a breast core biopsy yields lobular neoplasia?","volume":"199","author":"Niell","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"2020081219445696200_i1543-2165-141-12-1668-b65","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1245\/s10434-015-4922-4","article-title":"Incidence of adjacent synchronous invasive carcinoma and\/or ductal carcinoma in-situ in patients with lobular neoplasia on core biopsy: results from a prospective multi-institutional registry (TBCRC 020)","volume":"23","author":"Nakhlis","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2020081219445696200_i1543-2165-141-12-1668-b66","doi-asserted-by":"crossref","unstructured":"Susnik B, Day D, Abeln E, et al. Surgical outcomes of lobular neoplasia diagnosed in core biopsy: prospective study of 316 cases [published online ahead of print June 15, 2016]. Clin Breast Cancer. doi:10.1016\/j.clbc.2016.06.003.","DOI":"10.1016\/j.clbc.2016.06.003"},{"issue":"3","key":"2020081219445696200_i1543-2165-141-12-1668-b67","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2559.2010.03634.x","article-title":"Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis","volume":"57","author":"Carder","year":"2010","journal-title":"Histopathology"},{"issue":"3","key":"2020081219445696200_i1543-2165-141-12-1668-b68","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5306\/wjco.v5.i3.546","article-title":"Pleomorphic lobular carcinoma in situ of the breast: can the evidence guide practice?","volume":"5","author":"Pieri","year":"2014","journal-title":"World J Clin Oncol"},{"issue":"7","key":"2020081219445696200_i1543-2165-141-12-1668-b69","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.5858\/2009-0300-OA.1","article-title":"Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications","volume":"134","author":"Sullivan","year":"2010","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"2020081219445696200_i1543-2165-141-12-1668-b70","doi-asserted-by":"crossref","first-page":"927","DOI":"10.5858\/arpa.2012-0297-OA","article-title":"Pathologic upgrade rates on subsequent excision when lobular carcinoma in situ is the primary diagnosis in the needle core biopsy with special attention to the radiographic target","volume":"137","author":"D'Alfonso","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"2020081219445696200_i1543-2165-141-12-1668-b71","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2214\/AJR.05.0710","article-title":"Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up","volume":"187","author":"Mahoney","year":"2006","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"2020081219445696200_i1543-2165-141-12-1668-b72","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/01.MP.0000030450.20581.E3","article-title":"Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases","volume":"15","author":"Sneige","year":"2002","journal-title":"Mod Pathol"},{"key":"2020081219445696200_i1543-2165-141-12-1668-b73","article-title":"Breast cancer (version 1.2016)","author":"National Comprehensive Cancer Network"},{"issue":"3","key":"2020081219445696200_i1543-2165-141-12-1668-b74","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1245\/s10434-011-2034-3","article-title":"Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy","volume":"19","author":"Rendi","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2020081219445696200_i1543-2165-141-12-1668-b75","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00000658-197208000-00010","article-title":"Lobular carcinoma\u2014an indication for elective biopsy of the second breast","volume":"176","author":"Donegan","year":"1972","journal-title":"Ann Surg"},{"issue":"6","key":"2020081219445696200_i1543-2165-141-12-1668-b76","doi-asserted-by":"crossref","first-page":"737","DOI":"10.5858\/2010-0204-OA.1","article-title":"Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ","volume":"135","author":"Downs-Kelly","year":"2011","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"2020081219445696200_i1543-2165-141-12-1668-b77","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/tbj.12062","article-title":"Breast surgeon's survey: no consensus for surgical treatment of pleomorphic lobular carcinoma in situ","volume":"19","author":"Blair","year":"2013","journal-title":"Breast J"},{"issue":"18","key":"2020081219445696200_i1543-2165-141-12-1668-b78","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"2020081219445696200_i1543-2165-141-12-1668-b79","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"National Surgical Adjuvant Breast and Bowel Project (NSABP). Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"2020081219445696200_i1543-2165-141-12-1668-b80","article-title":"Breast cancer risk reduction (version 1.2016)","author":"National Comprehensive Cancer Network"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/141\/12\/1668\/1446001\/arpa_2016-0421-ra.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/141\/12\/1668\/1446001\/arpa_2016-0421-ra.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:38:30Z","timestamp":1764790710000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/141\/12\/article-p1668.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":80,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2016-0421-ra","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,1]]}}}